Navigation Links
Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study

MORRISVILLE, N.C.--(BUSINESS WIRE)--May 7, 2007 - BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced the results of a 12 subject, crossover study comparing the absorption of fentanyl from both single and multiple BEMA(TM) Fentanyl discs, as well as oral and intravenous doses of fentanyl. The data demonstrates that the absolute bioavailability (i.e. the total amount absorbed from the delivery system) of fentanyl from the BEMA(TM) disc was more than 70%, with 50% absorbed through the buccal mucosa (the inner lining of the cheek). The study further demonstrates that equal doses administered as either a single disc or multiple discs produced identical plasma concentrations (i.e. four-200 mcg discs provided the same plasma concentrations as a single-800 mcg disc).

These findings follow the company's April 25, 2007 announcement of statistically significant results with BEMA(TM) Fentanyl in treating cancer patients with breakthrough pain in the company's Phase III efficacy clinical trial. BDSI plans to include today's study results, the efficacy trial results and other materials in its planned New Drug Application (NDA) to the FDA for BEMA(TM) Fentanyl. The NDA submission is expected during the third quarter of 2007.

BEMA(TM) Fentanyl consists of a small, dissolvable polymer disc, formulated with the opioid narcotic fentanyl, for application to the buccal membranes. Upon administration, BEMA(TM) Fentanyl is designed to deliver a rapid, reliable dose of drug across mucous membranes. BEMA(TM) Fentanyl is being developed for the treatment of "breakthrough" cancer pain (i.e. episodes of severe pain which "break through" the medication already in use to control the persistent pain).

Dr. Andrew Finn, Executive Vice President of Product Development for BDSI, stated "The results of this study confirm, and are an expansion of, the information obtained in our 2006 pharmacokinetic study which demonstr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
2. BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
3. BDSI Announces Positive Phase III Clinical Trial Results for BEMA Fentanyl
4. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
5. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
6. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
7. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
8. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
9. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013 Z-Medica, a ... it has launched the first-ever line of products designed ... The line includes QuikClot ® EMS 4x4 Dressing, ... ® EMS Rolled Gauze™, all custom-designed to help ... they can be transported to a hospital or trauma ...
(Date:5/22/2013)... 22, 2013  MGT Capital Investments, Inc. (NYSE MKT: ... the Second Annual Marcum LLP MicroCap Conference on Thursday, ... at the Grand Hyatt Hotel.  ... will update investors and answer questions. (Logo: ... is scheduled to begin at 9:30 a.m. EDT.  MGT,s ...
(Date:5/22/2013)... , May 22, 2013 Hemoglobin A1C ... patients with Type 2 diabetes, while modest improvements ... health outcomes and can lead to substantial healthcare ... the International Society for Pharmacoeconomics and Outcomes Research ... two studies, sponsored by Valeritas, makers of the ...
Breaking Medicine Technology:Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... 21, 2011  BARRX Medical Inc., a leader in developing ... to remove precancerous tissue from the gastrointestinal tract, announces ... be acquired by Covidien.  Covidien is a leading global ... advanced energy-based devices.  Covidien will acquire ...
... NORRITON, Pa., Nov. 21, 2011 Tengion, Inc. (NASDAQ: ... today announced that Brian Davis, Vice President Finance and ... upcoming Piper Jaffray 23rd Annual Health Care Conference on ... A live audio webcast of the presentation ...
Cached Medicine Technology:BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 2BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 3Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference 2
(Date:5/22/2013)... Today, Zane Benefits, Inc. published a ... . Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution plans and health ... beginning in 2014 as part of the Affordable Care ... businesses will become available through new state health insurance ...
(Date:5/22/2013)... hospitals may be reaping enormous income for patients ... infections contracted in their intensive care units. , ... the American Journal of Medical Quality , ... develops an avoidable central line-associated bloodstream infection (CLABSI) ... than a similar infection-free patient. Moreover, hospitals earn ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...
(Date:5/22/2013)... WI (PRWEB) May 22, 2013 Unknown to ... their area at 30 mph. Minutes before it struck, ... of the nearing threat. This gave them time to reach ... & Data is proud to provide a product that ... occurs. A Wheelock SAFEPATH® SP40S Emergency Evacuation System ...
(Date:5/22/2013)... with heart failure are more likely to experience poorer ... mildly underactive, according to a new study. ... risk of death linked to the condition, which is ... first to show that African-Americans who have hypothyroidism face ... racial and ethnic groups," Dr. Connie Rhee, of Brigham ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2Health News:Underactive Thyroid and Heart Failure a Bad Combination: Study 2
... it will open its first spa this autumn in Japan, ... ,The Armani Group is opening its giant ... part of its strategy to lure customers in Japan, already ... square-foot) complex opening on November 8 will include a spa ...
... minister on Wednesday lamented opposition from several states to a ... report said . ,"In our country, we do ... that is why we have a billion population," Health Minister ... Day. ,"In our close-knit society, we have to ...
... foods protect against the clustering of abnormal body chemistry known ... Journal of Epidemiology and Community Health. ,The syndrome has ... disease, and premature death. ,The findings are based ... and 59, all of whom were part of a long ...
... the more number of blemishes or moles you have, the slower you ... compared key ageing DNA with the number of moles in a study ... found that the more moles a person had, the more likely their ... for the spotted to rejoice, as this is in spite of the ...
... in London are long overdue but it is unclear how ... improve patient care in the capital , BMA leaders claim. ... Council, said: There is a case for changing how some ... of these proposals may not be in the best interests ...
... MP3s in a storm can literally blow your brains out as ... . ,Most people who are struck by lightning are not ... jumps from the object that was hit. ,In 2006, ... a side flash from a tree that had been struck. ...
Cached Medicine News:Health News:Dotted All Over? - Count Yourself Lucky 2Health News:Polyclinics Could Threaten NHS Services, Warns BMA 2
... of the Robot Stainer HMS 760 X ... automatically lifted and transferred during program execution. ... drip preventing system contributes to a significant ... An acrylic glass cover and a vapor ...
... The Bright Starlet is the world's smallest cryostat! ... with a choice of handwheel or lever operation. ... easy-to-clean and resist common decontaminating agents. An insulated ... the refrigeration system and to reduce frosting when ...
... The Leica TP1020 product family are semi-enclosed ... perfect combination of approved technology with modern ... and maximum safety for tissues at all ... design based on proven precision mechanics in ...
... in a power assisted microtome combines the ... assisted horizontal movements are proportionally related to ... edge. Duplicate controls provide for convenient operation ... the operating levers and handles may be ...
Medicine Products: